We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RUSHB:NASDAQRush Enterprises, Inc. Analysis

Data as of 2026-08-08 - not real-time

$79.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At $79.04, Rush Enterprises, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it gained 4.0%. Relative strength is 58.4 — neutral — and the MACD signal is bullish. Watch $73.26 as support and $81.52 as the nearer resistance level.
Valuation screens as fair, on a P/E of 23.8 with no clean sector comparison available. The 0.71% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 29.8%, a beta of 0.69 and a maximum drawdown of 19.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.

Top Market Events

Revenues of $1.9 billion, net income of $72.8 millionEarnings per diluted share of $0.91Absorption ratio 130.8%Board...9dRush Enterprises targets closing refrigerated JV by August 31 as it expects a stronger second halfQ2 2026 earnings...NEW BRAUNFELS, Texas and OMAHA, Neb., July 23, 2026 GLOBE NEWSWIRE -- Rush Enterprises, Inc. NASDAQ: RUSHA & RUSHB ,...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 64.29
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 64.29
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Revenue contracting at -1.6%
  • P/E ratio of 23.8
  • Dividend yield of 0.71%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.60%
Profit Margin3.67%
P/E Ratio23.8
ROE11.79%
ROA4.95%
Debt/Equity63.08
P/B Ratio2.6

Technical Analysis

TrendBullish
RSI58.4
Support$73.26
Resistance$81.52
MA 20$77.03
MA 50$73.68
MA 200$64.29
MACDBullish
VolumeDecreasing
Fear & Greed Index94.82

Valuation

GradeFair
TypeBlend
Dividend Yield0.71%

Risk Assessment

Beta0.69
Volatility29.80%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.